Aplastic Anemia Clinical Trials

158 clinical trials for Aplastic Anemia across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia — RECRUITING · PHASE1
• Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome — RECRUITING · PHASE2
• Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy — RECRUITING · NA
• Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS — RECRUITING
• Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years — RECRUITING · PHASE2
• Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA — RECRUITING · PHASE2
• Revolade Tablets Specified Drug-use Survey — RECRUITING
• National Longitudinal Cohort of Hematological Diseases — RECRUITING
• A Study of Emapalumab for Pediatric Aplastic Anemia — RECRUITING · PHASE2
• Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors — RECRUITING · PHASE2
• A Prediction Model in Pregnant Women With Aplastic Anemia — RECRUITING
• Two Step Haplo With Radiation Conditioning — RECRUITING · PHASE2
• Umbilical Cord Blood Transplantation From Unrelated Donors — RECRUITING
• High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) — RECRUITING
• Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies — RECRUITING · PHASE1
• Reproductive and Mental Health of Patients With Aplastic Anemia — RECRUITING
• Haploidentical HCT for Severe Aplastic Anemia — RECRUITING · PHASE2
• Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia — RECRUITING · PHASE2
• CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia — RECRUITING · PHASE1
• A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia — COMPLETED · PHASE2
• Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients — NOT_YET_RECRUITING · PHASE3
• Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation — NOT_YET_RECRUITING · PHASE2
• Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE1
• Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia — WITHDRAWN · PHASE2
• Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA — WITHDRAWN · PHASE2
• Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA — WITHDRAWN · PHASE4
• Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia — ACTIVE_NOT_RECRUITING · PHASE2
• Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia — COMPLETED · PHASE2
• Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia — NOT_YET_RECRUITING · PHASE2
• A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies — COMPLETED · PHASE2
• Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study — COMPLETED · NA
• CK0801 for Treatment of Aplastic Anemia — NOT_YET_RECRUITING · PHASE2
• Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita — ACTIVE_NOT_RECRUITING · PHASE2
• Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders — COMPLETED · NA
• A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia — COMPLETED
• A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia — COMPLETED · PHASE2
• Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant — ACTIVE_NOT_RECRUITING
• Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. — COMPLETED · PHASE2
• UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia — NOT_YET_RECRUITING · PHASE2
• The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia — NOT_YET_RECRUITING · PHASE1
• ATGAM General Investigation — ACTIVE_NOT_RECRUITING
• Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies — COMPLETED · PHASE2
• Methadone as an Alternative Treatment for Children Underdoing HSCT — SUSPENDED · PHASE3
• Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia — COMPLETED · PHASE2
• Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia — ACTIVE_NOT_RECRUITING
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer — TERMINATED · PHASE2
• Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor — COMPLETED · PHASE2
• Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia — COMPLETED · NA
• CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly — COMPLETED · PHASE4
• Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies — COMPLETED · PHASE2

Refine this search